Ectopic pregnancy: Difference between revisions
Neil.m.young (talk | contribs) (brady can be featured in shock) |
Elcatracho (talk | contribs) |
||
(45 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Leading cause of maternal death in first trimester and overall third leading cause of maternal death | |||
*Leading cause of maternal death in first trimester | *Occur in 2% of all pregnancies<ref>Centers for Disease Control and Prevention. Current trends ectopic pregnancy - United States, 1990-92. MMWR Morb Mortal Wkly Rep. 1995; 44:46-48.</ref> and as high as 6-16% in those presenting to the ED<ref>Houry D and Keadey M. Complications in pregnancy part I: Early pregnancy. EBM. 2007; 9(6):1-28.</ref> | ||
*Pregnancy in patient with prior tubal ligation or IUD in place is ectopic until proven otherwise (25-50% are ectopic) | *Pregnancy in patient with prior tubal ligation or IUD in place is ectopic until proven otherwise (25-50% are ectopic) | ||
*Even if an IUP is visualized, there is a small risk of heterotopic ectopic pregnancy | *Even if an IUP is visualized, there is a small risk of heterotopic ectopic pregnancy | ||
Line 7: | Line 7: | ||
**IVF Population = 1 per 100 | **IVF Population = 1 per 100 | ||
===Risk Factors=== | ===Risk Factors<ref>Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996;65:1093–9</ref><ref>Mol BW, Ankum WM, Bossuyt PM, Van der Veen F. Contraception and the risk of ectopic pregnancy: a meta-analysis. Contraception. 1995;52:337–41.</ref>=== | ||
''Risk factors absent in almost half of patients'' | |||
{|class="wikitable" | {|class="wikitable" | ||
| align="center" style="background:*f0f0f0;"|'''Risk Factor''' | |||
| align="center" style="background: | | align="center" style="background:*f0f0f0;"|'''Odds Ratio''' | ||
| align="center" style="background: | |||
|- | |- | ||
| Previous tubal surgery||21 | | Previous tubal surgery||21 | ||
Line 28: | Line 28: | ||
|} | |} | ||
== | ===Specific Types by Location=== | ||
''Most common location is the ampulla of the fallopian tube'' | |||
== | ====Cervical Ectopic==== | ||
===Clinical Features== | *Very rare with delayed diagnoses due to decreased accuracy of US | ||
*As high as 10% with reproductive IVF | |||
====Interstitial Ectopic==== | |||
*Typically presents after 8 wks, with rupture possibly occurring as early as 5 wks | |||
*Implantation in myometrium in proximal part of fallopian tube, commonly misdiagnosed on [[ultrasound]] as intrauterine pregnancy | |||
*65% diagnosis on [[ultrasound]] and laparascopy is gold standard | |||
*US characteristics: | |||
**Empty uterus | |||
**Gestational sac separate from endometrium | |||
**Gestational sac > 1 cm from lateral aspect of uterine cavity | |||
**< 5 mm mantle surrounding the sac | |||
==Clinical Features== | |||
''Must consider in all women of childbearing age with [[abdominal pain|abdominal]] and/or [[pelvic pain]]'' | |||
*Ruptured | |||
**[[hemorrhagic shock|Shock]] | |||
**Rebound tenderness | |||
*Non-ruptured (early) | |||
**[[abdominal pain|Abdominal]]/[[pelvic pain]] | |||
**[[Vaginal bleeding]] | |||
==Differential Diagnosis== | |||
{{VB DDX less than 20}} | |||
{{Pelvic pain DDX}} | |||
==Evaluation== | |||
[[File:Ectopic Pregnancy Rutz.gif|thumbnail|Ultrasound shows ectopic pregnancy<ref>http://www.thepocusatlas.com/obgyn/</ref>]] | |||
[[File:Ectopic Ultrasound.png|thumb|Algorithm for the Evaluation of Suspected Ectopic Pregnancy]] | |||
===Work-Up=== | |||
*hemoglobin (or CBC)<ref>Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician. 2005;72;1707-1714, 1719-1720</ref> | |||
*[[Beta-HCG Levels|Beta-HCG (quantitative)]] | |||
*Type and Screen with Rh Factor | |||
*[[FAST exam|FAST]] and [[Ultrasound: Pelvic|Pelvic US]] | |||
===Diagnostic Algorithm=== | ===Diagnostic Algorithm=== | ||
''Using this algorithm should always favor considering ectopic if there is any evolution or change in a patient's clinical exam<ref>American College of Obstetricians and Gynecologists. Medical management of tubal pregnancy. Number 3, December 1998. Clinical management guidelines for obstetricians-gynecologists. Int J Gynaecol Obstet. 1999;65:97–103</ref>'' | |||
{| class="wikitable" | {| class="wikitable" | ||
|+'''Estimating the Risk for Ectopic Pregnancy<ref>Buckley RG, King K et. al. History and physical examination to estimate the risk of ectopic pregnancy: validation of a clinical prediction model. Ann Emerg Med. 1999;34:589–94</ref>''' | |+'''Estimating the Risk for Ectopic Pregnancy<ref>Buckley RG, King K et. al. History and physical examination to estimate the risk of ectopic pregnancy: validation of a clinical prediction model. Ann Emerg Med. 1999;34:589–94</ref>''' | ||
| align="center" style="background: | | align="center" style="background:*f0f0f0;"|'''Clinical Signs and Symptoms''' | ||
| align="center" style="background: | | align="center" style="background:*f0f0f0;"|'''Risk Group''' | ||
| align="center" style="background: | | align="center" style="background:*f0f0f0;"|'''Percent Risk of Ectopic (%)''' | ||
|- | |- | ||
| Peritoneal irritation or cervical motion tenderness||High||29 | | Peritoneal irritation or cervical motion tenderness||High||29 | ||
Line 57: | Line 83: | ||
|} | |} | ||
====Step one==== | |||
===Step one=== | |||
*Assess for [[Shock]] | *Assess for [[Shock]] | ||
**Beware that paradoxical bradycardia can be present with significant hemoperitoneum<ref>Hick JL, et al. Vital signs fail to correlate with hemoperitoneum from ruptured ectopic pregnancy. The American Journal of Emergency Medicine. 2001; 19(6)488–491.</ref> | **Beware that paradoxical bradycardia can be present with significant hemoperitoneum<ref>Hick JL, et al. Vital signs fail to correlate with hemoperitoneum from ruptured ectopic pregnancy. The American Journal of Emergency Medicine. 2001; 19(6)488–491.</ref> | ||
*If patient is a high risk for ectopic based on above estimation then immediately contact OBGYN | *If patient is a high risk for ectopic based on above estimation then immediately contact OBGYN | ||
===Step Two=== | ====Step Two==== | ||
'''Perform a [[Pelvic US]]''' | '''Perform a [[Pelvic US]]''' | ||
*Consider Transabdominal Ultrasound for B-HCG: >6000 mIU/ml (but if negative or indeterminate must do Pelvic | *Consider Transabdominal Ultrasound for B-HCG: >6000 mIU/ml (but if negative or indeterminate must do Pelvic [[ultrasound]] regardless of B-HCG) | ||
'''Is there an Intrauterine Pregnancy?''' | '''Is there an Intrauterine Pregnancy?''' | ||
*If there is an IUP and there was no assisted reproductive fertility used then ectopic ruled out and heterotopic unlikely (less than 1:30,000)<ref>Mukul LV, Teal SB. Current management of ectopic pregnancy. Obstet Gynecol Clin N Am. 2007; 34:403-419. </ref> | *If there is an IUP and there was no assisted reproductive fertility used then ectopic ruled out and heterotopic unlikely (less than 1:30,000)<ref>Mukul LV, Teal SB. Current management of ectopic pregnancy. Obstet Gynecol Clin N Am. 2007; 34:403-419. </ref> | ||
*If fertility assistance was used then still consider a heterotopic (1% risk)<ref>Yeh HC, Goodman JD, Carr L, et al. Intradecidual sign: a | *If fertility assistance was used then still consider a heterotopic (1% risk)<ref>Yeh HC, Goodman JD, Carr L, et al. Intradecidual sign: a [[ultrasound]] criterion of early intrauterine pregnancy. Radiology. 1986;161:463-467</ref> | ||
===Step Three=== | ====Step Three==== | ||
* If HCG above Discriminatory Zone (>1,500-3,000 mIU/ml) and not visualized it should be an ectopic pregnancy until proven otherwise | *If HCG above Discriminatory Zone (>1,500-3,000 mIU/ml) and not visualized it should be an ectopic pregnancy until proven otherwise | ||
===Step Four=== | ====Step Four==== | ||
*Arrange close | *Arrange close follow-up for patients with no visualized IUP and B-HCG( (<1,500-3,000 mIU/ml), with minimal to no pain and hemodynamically stable. | ||
*Patients should have a 48hr repeat B-HCG level checked to determine if appropriate doubling is occurring. | *Patients should have a 48hr repeat B-HCG level checked to determine if appropriate doubling is occurring. | ||
{{Repeat B-hCG levels}} | {{Repeat B-hCG levels}} | ||
== | ==Management== | ||
#[[Rho(D) Immune Globulin (RhoGAM)|RhoGAM]] for all Rh-negative women | |||
#OB/GYN Consult | |||
#Medical management with [[methotrexate]] (ACOG) | |||
#*Single dose regimen<ref>Bachman EA and Barnhart K. Medical Management of Ectopic Pregnancy: A Comparison of Regimens. Clin Obstet Gynecol. 2012 Jun; 55(2): 440–447.</ref> | |||
#**[[Methotrexate]] 50mg/m2 IM day 1 | |||
#**If hCG decreases by <15% between days 4 and 7, another 50mg/m2 IM [[methotrexate]] on day 7 | |||
#*Absolute contraindications | |||
#**Breast-feeding | |||
#**Laboratory evidence of immunodeficiency | |||
#**Preexisting blood dyscrasias (bone marrow hypoplasia, [[leukopenia]], [[thrombocytopenia]], or clinically significant [[anemia]]) | |||
#**Known sensitivity to methotrexate | |||
#**Active pulmonary disease | |||
#**[[Peptic ulcer disease]] | |||
#**Hepatic, renal, or hematologic dysfunction | |||
#**Alcoholism | |||
#**Alcoholic or other chronic liver disease | |||
#**Coexistant viable IUP | |||
#**Does not have timely access to medical institution, or unwilling/unable to comply with post-MTX monitoring | |||
#*Relative contraindications | |||
#**Adnexal mass >3.5 cm in largest diameter | |||
#**Presence of fetal heart rate | |||
#**Free fluid visualized in Pouch of Douglas | |||
#**[[Beta-HCG]] >5000mIU/mL | |||
#*Note: Need to counsel patient to return after 4 and 7 days to recheck hCG values to check for satisfactory decline | |||
#*Also note that 30-60% of women experience "separation pain" ~1 week after starting methotrexate<ref>Lipscomb GH et al. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol. 1999 Apr;93(4):590-3.</ref> | |||
#**Thought to be due to tubal distention from tubal abortion or hematoma formation | |||
#**Nevertheless, presentation of abdominal pain at this time still warrants an US to look for tubal rupture, which may be indicated by increase in pelvic free fluid, decrease in Hb | |||
#**Size of ectopic mass may actually increase before involution, and this is not associated with treatment failure | |||
#Surgical treatment | |||
#*Urgent laparotomy if patient is unstable | |||
#*Otherwise, laparascopic salpingectomy or salpingostomy can be done | |||
== | ==Disposition== | ||
*Most are admitted and/or go to the OR | |||
*Smaller, minimally symptomatic ectopic pregnancies being treated with methotrexate may be discharged in consultation with OB/GYN | |||
== | ==See Also== | ||
*[[Pregnancy (main)]] | |||
*[[methotrexate toxicity]] | |||
==External Links== | ==External Links== | ||
*[http://www.mdcalc.com/pregnancy-due-dates-calculator/ MDCalc - Pregnancy Due Dates Calculation] | *[http://www.mdcalc.com/pregnancy-due-dates-calculator/ MDCalc - Pregnancy Due Dates Calculation] | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:OBGYN]] |
Revision as of 23:28, 8 February 2021
Background
- Leading cause of maternal death in first trimester and overall third leading cause of maternal death
- Occur in 2% of all pregnancies[1] and as high as 6-16% in those presenting to the ED[2]
- Pregnancy in patient with prior tubal ligation or IUD in place is ectopic until proven otherwise (25-50% are ectopic)
- Even if an IUP is visualized, there is a small risk of heterotopic ectopic pregnancy
- General Population = 1 per 4000
- IVF Population = 1 per 100
Risk Factors[3][4]
Risk factors absent in almost half of patients
Risk Factor | Odds Ratio |
Previous tubal surgery | 21 |
Previous ectopic pregnancy | 8.3 |
Diethylstilbestrol exposure | 5.6 |
Previous PID | 2.4 to 3.7 |
Assisted Fertility | 2 to 2.5 |
Smoker | 2.3 |
Previous intrauterine device use | 1.6 |
Specific Types by Location
Most common location is the ampulla of the fallopian tube
Cervical Ectopic
- Very rare with delayed diagnoses due to decreased accuracy of US
- As high as 10% with reproductive IVF
Interstitial Ectopic
- Typically presents after 8 wks, with rupture possibly occurring as early as 5 wks
- Implantation in myometrium in proximal part of fallopian tube, commonly misdiagnosed on ultrasound as intrauterine pregnancy
- 65% diagnosis on ultrasound and laparascopy is gold standard
- US characteristics:
- Empty uterus
- Gestational sac separate from endometrium
- Gestational sac > 1 cm from lateral aspect of uterine cavity
- < 5 mm mantle surrounding the sac
Clinical Features
Must consider in all women of childbearing age with abdominal and/or pelvic pain
- Ruptured
- Shock
- Rebound tenderness
- Non-ruptured (early)
Differential Diagnosis
Vaginal Bleeding in Pregnancy (<20wks)
- Ectopic pregnancy
- Subchorionic hematoma
- First Trimester Abortion
- Complete Abortion
- Incomplete Abortion
- Inevitable Abortion
- Missed Abortion
- Septic abortion
- Threatened Abortion
- Gestational trophoblastic disease
- Consider when pregnancy-induced hypertension is seen before 24 wks of gestation
- Heterotopic pregnancy
- Implantation bleeding
- Molar pregnancy
- Non-pregnancy related bleeding
- Cervicitis
- Fibroids
- Implantation bleeding
Acute Pelvic Pain
Gynecologic/Obstetric
- Pregnancy-related
- Ectopic Pregnancy
- Spontaneous abortion, threatened or incomplete
- Septic abortion
- Acute Infections
- Vulvovaginitis
- Adnexal Disorders
- Hemorrhage/rupture of ovarian cyst
- Ovarian torsion
- Twisted paraovarian cyst
- Other
- Myoma (degenerating)
- Genitourinary trauma
- Ovarian hyperstimulation syndrome
- Sexual assault
- Recurrent
- Mittelschmerz
- Primary/Secondary Dysmenorrhea
- Pelvic Congestion Syndrome
- Endometriosis
Genitourinary
Gastrointestinal
- Gastroenteritis
- Appendicitis
- Bowel obstruction
- Perirectal abscess
- Diverticulitis
- Inflammatory bowel disease
- Irritable bowel syndrome
- Mesenteric adenitis
Musculoskeletal
- Abdominal wall hematoma
- Psoas hematoma, psoas abscess
- Hernia
Vascular
- Pelvic thrombophlebitis
- Abdominal aortic aneurysm
- Ischemic bowel (Mesenteric Ischemia)
Evaluation
Work-Up
- hemoglobin (or CBC)[7]
- Beta-HCG (quantitative)
- Type and Screen with Rh Factor
- FAST and Pelvic US
Diagnostic Algorithm
Using this algorithm should always favor considering ectopic if there is any evolution or change in a patient's clinical exam[8]
Clinical Signs and Symptoms | Risk Group | Percent Risk of Ectopic (%) |
Peritoneal irritation or cervical motion tenderness | High | 29 |
No fetal heart tones; no tissue at cervical os; pain present | Intermediate | 7 |
Fetal heart tones or tissue at cervical os; no pain | <1 |
Step one
- Assess for Shock
- Beware that paradoxical bradycardia can be present with significant hemoperitoneum[10]
- If patient is a high risk for ectopic based on above estimation then immediately contact OBGYN
Step Two
Perform a Pelvic US
- Consider Transabdominal Ultrasound for B-HCG: >6000 mIU/ml (but if negative or indeterminate must do Pelvic ultrasound regardless of B-HCG)
Is there an Intrauterine Pregnancy?
- If there is an IUP and there was no assisted reproductive fertility used then ectopic ruled out and heterotopic unlikely (less than 1:30,000)[11]
- If fertility assistance was used then still consider a heterotopic (1% risk)[12]
Step Three
- If HCG above Discriminatory Zone (>1,500-3,000 mIU/ml) and not visualized it should be an ectopic pregnancy until proven otherwise
Step Four
- Arrange close follow-up for patients with no visualized IUP and B-HCG( (<1,500-3,000 mIU/ml), with minimal to no pain and hemodynamically stable.
- Patients should have a 48hr repeat B-HCG level checked to determine if appropriate doubling is occurring.
Repeat B-hCG Levels
Pregnancy Type | B-hCG Change |
Normal |
|
Ectopic |
|
Miscarriage |
|
^Initial level CANNOT be used to rule-out ectopic
Management
- RhoGAM for all Rh-negative women
- OB/GYN Consult
- Medical management with methotrexate (ACOG)
- Single dose regimen[13]
- Methotrexate 50mg/m2 IM day 1
- If hCG decreases by <15% between days 4 and 7, another 50mg/m2 IM methotrexate on day 7
- Absolute contraindications
- Breast-feeding
- Laboratory evidence of immunodeficiency
- Preexisting blood dyscrasias (bone marrow hypoplasia, leukopenia, thrombocytopenia, or clinically significant anemia)
- Known sensitivity to methotrexate
- Active pulmonary disease
- Peptic ulcer disease
- Hepatic, renal, or hematologic dysfunction
- Alcoholism
- Alcoholic or other chronic liver disease
- Coexistant viable IUP
- Does not have timely access to medical institution, or unwilling/unable to comply with post-MTX monitoring
- Relative contraindications
- Adnexal mass >3.5 cm in largest diameter
- Presence of fetal heart rate
- Free fluid visualized in Pouch of Douglas
- Beta-HCG >5000mIU/mL
- Note: Need to counsel patient to return after 4 and 7 days to recheck hCG values to check for satisfactory decline
- Also note that 30-60% of women experience "separation pain" ~1 week after starting methotrexate[14]
- Thought to be due to tubal distention from tubal abortion or hematoma formation
- Nevertheless, presentation of abdominal pain at this time still warrants an US to look for tubal rupture, which may be indicated by increase in pelvic free fluid, decrease in Hb
- Size of ectopic mass may actually increase before involution, and this is not associated with treatment failure
- Single dose regimen[13]
- Surgical treatment
- Urgent laparotomy if patient is unstable
- Otherwise, laparascopic salpingectomy or salpingostomy can be done
Disposition
- Most are admitted and/or go to the OR
- Smaller, minimally symptomatic ectopic pregnancies being treated with methotrexate may be discharged in consultation with OB/GYN
See Also
External Links
References
- ↑ Centers for Disease Control and Prevention. Current trends ectopic pregnancy - United States, 1990-92. MMWR Morb Mortal Wkly Rep. 1995; 44:46-48.
- ↑ Houry D and Keadey M. Complications in pregnancy part I: Early pregnancy. EBM. 2007; 9(6):1-28.
- ↑ Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996;65:1093–9
- ↑ Mol BW, Ankum WM, Bossuyt PM, Van der Veen F. Contraception and the risk of ectopic pregnancy: a meta-analysis. Contraception. 1995;52:337–41.
- ↑ Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
- ↑ http://www.thepocusatlas.com/obgyn/
- ↑ Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician. 2005;72;1707-1714, 1719-1720
- ↑ American College of Obstetricians and Gynecologists. Medical management of tubal pregnancy. Number 3, December 1998. Clinical management guidelines for obstetricians-gynecologists. Int J Gynaecol Obstet. 1999;65:97–103
- ↑ Buckley RG, King K et. al. History and physical examination to estimate the risk of ectopic pregnancy: validation of a clinical prediction model. Ann Emerg Med. 1999;34:589–94
- ↑ Hick JL, et al. Vital signs fail to correlate with hemoperitoneum from ruptured ectopic pregnancy. The American Journal of Emergency Medicine. 2001; 19(6)488–491.
- ↑ Mukul LV, Teal SB. Current management of ectopic pregnancy. Obstet Gynecol Clin N Am. 2007; 34:403-419.
- ↑ Yeh HC, Goodman JD, Carr L, et al. Intradecidual sign: a ultrasound criterion of early intrauterine pregnancy. Radiology. 1986;161:463-467
- ↑ Bachman EA and Barnhart K. Medical Management of Ectopic Pregnancy: A Comparison of Regimens. Clin Obstet Gynecol. 2012 Jun; 55(2): 440–447.
- ↑ Lipscomb GH et al. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol. 1999 Apr;93(4):590-3.